ArticleJCO precision oncology2026

Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2-Low Stage IV Breast Cancer: A Multicenter Retrospective Study.

Chia Jie Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.